Nancy A. Melville

Articles

The new eyelash growth product Latisse (bimatoprost ophthalmic solution 0.03 percent, Allergan) is gaining a strong following among patients and their doctors.

Eyes wide open: Patients, physicians embrace eyelash growth product

Topical and phototherapy treatment options for vitiligo are increasing, and one expert says he combines modalities.

The big picture: Phototherapy, topical combinations help improve vitiligo

Vascular lasers remain the gold standard for treating more severe cases of rosacea, including acne rosacea.

Treating rosacea: Effective lasers don't have to put physicians in the red

When female patients present with a combination of hair loss, hirsutism and acne, physicians should check total testosterone levels.

Getting to the root: Look below the surface for cause of hyperandrogenetic symptoms

Physicians have more options than ever available for wound dressings, and while many newer products come with a high price tag, their efficacy may make the cost worthwhile. One new product, honey, actually dates back to ancient times, and recent studies support some wound-healing benefits, specifically from manuka honey, produced in New Zealand.

Choosing the right dressing: Options are plentiful in 'Wild West' of woundcare

In the beginning, there was only Botox, but after years of owning the U.S. market with no competition, Allergan's brand of botulinum toxin will inevitably soon share the stage with several new neurotoxins that are working their way towards FDA approval.

New forms of botulinum toxin type A emerge, compete for neurotoxin market

As fillers evolve to address an ever-expanding array of aging skin issues, the term filler, itself, is almost becoming obsolete as modern-day products do far more than fill wrinkles. Using them to just fill, in fact, is kind of like using a Ferrari for trips to the local convenience store, said Wm. Philip Werschler, M.D., F.A.A.D., F.A.A.C.S.

The changing face of fiillers

National report - New drug combinations and concentrations loom for teen acne treatment as researchers strive to address as many pathogenic targets as possible while upping the ante on treatment efficacy.

Acne research pushes for new combinations, probes isotretinoin's secrets

Dr. Witman has prescribed the agents as second-line therapy after a first-line therapy attempt with topical corticosteroids failed, or if potential side effects of topical steroids would make their use contraindicated.

Making a case for 'marked' meds

National report - New topical steroids that have recently hit the market may not be for everyone, but for the right pediatric patients, the products represent exciting new developments in the treatment of pediatric dermatoses, says Joel Schlessinger, M.D., director of the Advanced Skin Research Center in Omaha, Neb., and president of the American Society of Cosmetic Dermatology and Aesthetic Surgery.

Author | Nancy A. Melville

Articles

New content coming soon, please check back later.